82 related articles for article (PubMed ID: 18413785)
1. Response to letter of Vahle et al.
Jolette J; Wilker CE; Fox J
Toxicol Pathol; 2008 Apr; 36(3):520-1. PubMed ID: 18413785
[No Abstract] [Full Text] [Related]
2. Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data.
Vahle JL; Sato M; Long GG
Toxicol Pathol; 2007 Dec; 35(7):1045-6. PubMed ID: 18098050
[No Abstract] [Full Text] [Related]
3. Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.
Vahle JL; Long GG; Sandusky G; Westmore M; Ma YL; Sato M
Toxicol Pathol; 2004; 32(4):426-38. PubMed ID: 15204966
[TBL] [Abstract][Full Text] [Related]
4. Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats.
Jolette J; Wilker CE; Smith SY; Doyle N; Hardisty JF; Metcalfe AJ; Marriott TB; Fox J; Wells DS
Toxicol Pathol; 2006; 34(7):929-40. PubMed ID: 17178693
[TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
6. A measure of tumorigenic potency incorporating dose-response shape.
Meier KL; Bailer AJ; Portier CJ
Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
[TBL] [Abstract][Full Text] [Related]
7. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments.
Portier CJ; Bailer AJ
J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366
[TBL] [Abstract][Full Text] [Related]
8. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
Lutz WK
Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
[No Abstract] [Full Text] [Related]
9. Estimation of k for the poly-k test with application to animal carcinogenicity studies.
Moon H; Ahn H; Kodell RL; Lee JJ
Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548
[TBL] [Abstract][Full Text] [Related]
10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
11. Thresholds in carcinogenicity in ED01 study.
Rozman KK
Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
[No Abstract] [Full Text] [Related]
12. Bioassay design and MTD setting: old methods and new approaches.
Swenberg JA
Regul Toxicol Pharmacol; 1995 Feb; 21(1):44-51; discussion 81-6. PubMed ID: 7784635
[TBL] [Abstract][Full Text] [Related]
13. Excess mortality in two-year rodent carcinogenicity studies.
Roth A; Kadyszewski E; Geffray B; Paulissen J; Weaver RJ
Toxicol Pathol; 2007 Dec; 35(7):1040-3. PubMed ID: 18098048
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic response of F344 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4'-methylenebis(N,N-dimethyl)-benzenamine, 4,4'-oxydianiline, and 4,4'-methylenedianiline.
Weisburger EK; Murthy AS; Lilja HS; Lamb JC
J Natl Cancer Inst; 1984 Jun; 72(6):1457-63. PubMed ID: 6587162
[TBL] [Abstract][Full Text] [Related]
15. Appropriate parameters to be tested in rodent oncogenicity studies.
Long GG; Symanowski JT
Toxicol Pathol; 1998; 26(3):319-20. PubMed ID: 9608637
[No Abstract] [Full Text] [Related]
16. Usefulness of in vivo short-term studies on carcinogenic risk assessment.
Takahashi M
J Toxicol Sci; 1995 Sep; 20(4):465-7. PubMed ID: 8531243
[No Abstract] [Full Text] [Related]
17. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
Johnson FM
Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
[TBL] [Abstract][Full Text] [Related]
18. Dose-response studies with nitrosoheptamethyleneimine and its alpha-deuterium-labeled derivative in F344 rats.
Lijinsky W; Reuber MD; Davies TS; Riggs CW
J Natl Cancer Inst; 1982 Nov; 69(5):1127-33. PubMed ID: 6957657
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of butylated hydroxyanisole in F344 rats.
Ito N; Fukushima S; Hagiwara A; Shibata M; Ogiso T
J Natl Cancer Inst; 1983 Feb; 70(2):343-52. PubMed ID: 6571941
[TBL] [Abstract][Full Text] [Related]
20. Lack of carcinogenicity of triethanolamine in F344 rats.
Maekawa A; Onodera H; Tanigawa H; Furuta K; Kanno J; Matsuoka C; Ogiu T; Hayashi Y
J Toxicol Environ Health; 1986; 19(3):345-57. PubMed ID: 3772984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
